Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Eli Lilly's 415-acre Concord project is expected to house a five-building campus with manufacturing, logistics, a quality-control lab and central utilities plant.

Eli Lilly plans to build 12 buildings on its new campus, including two 330,000-square-foot peptide manufacturing facilities. Doyel: Myles Turner, his agent and Bucks taught us some lessons, some ...

Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.

Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.

The deal, announced June 17, includes a cash offer of $10.50 per share for all outstanding Verve stock. Lilly may also pay as ...

Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 ...

Eli Lilly faces market headwinds, slowing growth, and rising competition. Discover why now might be the time for LLY ...

LEBANON, Ind. — Eli Lilly and Company wants to be able to produce the supply of all its medicines Americans need right here in the United States. Much of that medicine will be produced at a ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

But Eli Lilly's supply woes began to ease earlier this year, and the Food and Drug Administration removed tirzepatide, the active ingredient in Mounjaro and Zepbound, from its shortage list.

The Eli Lilly logo sign atop Lilly Biotechnology Center campus building Eli Lilly will acquire Verve for roughly $1 billion Verve is developing a one-time gene-editing treatment for heart disease ...